Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

被引:104
|
作者
Steinauer, KK [1 ]
Gibbs, I [1 ]
Ning, SC [1 ]
French, JN [1 ]
Armstrong, J [1 ]
Knox, SJ [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
cyclooxygenase-2; radiation; prostate cancer; prostaglandin E-2; NS-398;
D O I
10.1016/S0360-3016(00)00671-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the impact of gamma-irradiation on cyclooxygenase-2 (COX-2) expression and its enzymatic activity in PC-3 cells. Cell cycle redistribution, viability, and apoptosis were quantitated in control and irradiated cells with or without the COX-2 inhibitor NS-398. Methods and Materials: Western blot analysis was used to assess COX-2 protein expression, Prostaglandin (PGE,) was measured after addition of arachidonic acid (AA) using a Monoclonal Immunoassay Kit. Cell cycle and apoptosis were assessed using flow cytometry. Results: We observed a dose-dependent increase in COX-2 of 37.0%, 79.7%, and 97.5% following irradiation with 5,10, and 15 Gy, respectively. The PGE(2) level of irradiated cells was higher than in controls (1512 +/- 157.5 vs. 973.7 +/- 54.2 rho g PGE(2)/mL; p < 0.005, n = 4) while cells irradiated in the presence of NS-398 had reduced PGE(2) levels (218.8 +/- 80.1 rho g PGE(2)/mL; p < 0.005; n = 4), We found no differences in cell cycle distribution or apoptosis between cells irradiated in the presence or absence of NS-398, Conclusions: COX-2 protein is upregulated and enzymatically active after irradiation, resulting in elevated levels of PGE(2). This effect can be suppressed by NS-398, which has clinical implications for therapies combining COX-2 inhibitors with radiation therapy. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:325 / 328
页数:4
相关论文
共 50 条
  • [1] Gastroprotective agent rebamipide induces cyclooxygenase-2 (COX-2) in gastric epithelial cells
    Murata, H
    Yabe, Y
    Tsuji, S
    Tsujii, M
    Fu, HY
    Asahi, K
    Eguchi, H
    Kawano, S
    Hayashi, N
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (Suppl 1) : S70 - S75
  • [2] Gastroprotective Agent Rebamipide Induces Cyclooxygenase-2 (COX-2) in Gastric Epithelial Cells
    Hiroaki Murata
    Yuki Yabe
    Shingo Tsuji
    Masahiko Tsujii
    Hai Ying Fu
    Kayoko Asahi
    Hiroshi Eguchi
    Sunao Kawano
    Norio Hayashi
    Digestive Diseases and Sciences, 2005, 50 : S70 - S75
  • [3] Cyclooxygenase-2 (Cox-2) in Newborn Lung
    P Lassus
    H Wolff
    S Andersson
    Pediatric Research, 1999, 45 (6) : 887 - 887
  • [4] Cancer and cyclooxygenase-2 (COX-2) inhibition
    Evans, JF
    Kargman, SL
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 627 - 634
  • [5] Cyclooxygenase-2 (Cox-2) expression in lymphomas
    Hazar, B
    Ergin, M
    Seyrek, E
    Erdogan, E
    Tuncer, I
    Hakverdi, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (07) : 1395 - 1399
  • [6] Cyclooxygenase-2 (COX-2) siRNA inhibits the expression of COX-2 protein and the growth of human hepatocellular carcinoma cells.
    Park, JW
    Park, JE
    Lee, JA
    Lee, CW
    Kim, CM
    HEPATOLOGY, 2004, 40 (04) : 373A - 373A
  • [7] Cyclooxygenase-2 (COX-2) expression in retinoblastoma
    Mendez, MC
    Fernandes, L
    Caissie, AL
    Callejo, SA
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U605 - U605
  • [8] Cyclooxygenase-2 (COX-2) in newborn lung
    Lassus, P
    Wolff, H
    Andersson, S
    PEDIATRIC RESEARCH, 1999, 45 (06) : 887 - 887
  • [9] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
    Graham, Kamara Whitney
    Sevigny, Mary B.
    Gabriel, Bianca S.
    FASEB JOURNAL, 2009, 23
  • [10] Roles of cyclooxygenase-2 (COX-2) in gastrointestinal (GI) carcinogenesis; focusing on COX-2 expressing cells
    Bamba, Hiromi
    Arai, Shin
    Ban, Shinichi
    Goto, Yoshiya
    Imai, Yukinori
    Kawamoto, Chiaki
    Shimizu, Michio
    Ota, Shinichi
    CANCER RESEARCH, 2006, 66 (08)